Precipitating pharmakologies and capital entrapments: narcolepsy and the strange cases of Provigil and Xyrem.
Since the mid-1990s, Americans have been made more aware of chronic sleep deprivation and sleep disorders exacerbated by dominant temporal regimes of work, school, and family life, primarily through increased medical and media attention. Concomitantly, Americans have turned to medical treatments and pharmaceutical cocktails to achieve normalcy rather than attending to the social and cultural causes of sleep sickness. This turn toward pharmaceuticalization is aided in part by the proliferation of medical disorders and the pharmaceuticals marketed to treat them (e.g., "excessive daytime sleepiness" requires treatment once reserved for narcoleptics). These cocktails have explicit and implicit components: the former consist of pharmaceuticals, the latter of capital dependencies, including ties to medical insurance companies, stable employment, and familial networks. In this article, I examine the proliferation of pharmaceutical cocktails through the concept of the pharmakon-something simultaneously remedy and cause-to illuminate the causes and effects of such pharmaceutical regimens in contemporary American society, specifically those relating to sleepiness. Specific cases of this struggle between chemical dependence and normalcy are offered from my ethnographic work with patients who suffer from sleep disorders.
Wolf-Meyer
Matthew
M
Department of Anthropology, University of California, Santa Cruz, CA 95064, USA. mwolfmey@ucsc.edu
D000759:Adjuvants, Anesthesia / Q000627:therapeutic use*; D000328:Adult; D000329:Advertising; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006970:Disorders of Excessive Somnolence / Q000188:drug therapy* / Q000209:etiology; D004345:Drug Industry / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D000077408:Modafinil; D009290:Narcolepsy / Q000188:drug therapy / Q000523:psychology; D010342:Patient Acceptance of Health Care; D010565:Persuasive Communication; D012892:Sleep Deprivation / Q000150:complications; D012978:Sodium Oxybate / Q000627:therapeutic use*; D055815:Young Adult
D000759:Adjuvants, Anesthesia; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D012978:Sodium Oxybate; D000077408:Modafinil